FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3015311442> ?p ?o ?g. }

• W3015311442 endingPage "1713" @default.
• W3015311442 startingPage "1705" @default.
• W3015311442 abstract "Endothelium-derived prostacyclin and nitric oxide elevate platelet cyclic nucleotide levels and maintain quiescence. We previously demonstrated that a synergistic relationship exists between cyclic nucleotides and P2Y12 receptor inhibition. A number of clinically approved drug classes can modulate cyclic nucleotide tone in platelets including activators of NO-sensitive guanylyl cyclase (GC) and phosphodiesterase (PDE) inhibitors. However, the doses required to inhibit platelets produce numerous side effects including headache.We investigated using GC-activators in combination with P2Y12 receptor antagonists as a way to selectively amplify the anti-thrombotic effect of both drugs.In vitro light transmission aggregation and platelet adhesion under flow were performed on washed platelets and platelet rich plasma. Aggregation in whole blood and a ferric chloride-induced arterial thrombosis model were also performed.The GC-activator BAY-70 potentiated the action of the P2Y12 receptor inhibitor prasugrel active metabolite in aggregation and adhesion studies and was associated with raised intra-platelet cyclic nucleotide levels. Furthermore, mice administered sub-maximal doses of the GC activator cinaciguat together with the PDE inhibitor dipyridamole and prasugrel, showed significant inhibition of ex vivo platelet aggregation and significantly reduced in vivo arterial thrombosis in response to injury without alteration in basal carotid artery blood flow.Using in vitro, ex vivo, and in vivo functional studies, we show that low dose GC activators synergize with P2Y12 inhibition to produce powerful anti-platelet effects without altering blood flow. Therefore, modulation of intra-platelet cyclic nucleotide levels alongside P2Y12 inhibition can provide a strong, focused anti-thrombotic regimen while minimizing vasodilator side effects." @default.
• W3015311442 created "2020-04-17" @default.
• W3015311442 creator A5002943978 @default.
• W3015311442 creator A5049732997 @default.
• W3015311442 creator A5056483000 @default.
• W3015311442 creator A5059950825 @default.
• W3015311442 creator A5063653314 @default.
• W3015311442 creator A5064169659 @default.
• W3015311442 creator A5070871944 @default.
• W3015311442 creator A5074359004 @default.
• W3015311442 creator A5091566580 @default.
• W3015311442 date "2020-07-01" @default.
• W3015311442 modified "2023-10-16" @default.
• W3015311442 title "Combination of cyclic nucleotide modulators with P2Y12 receptor antagonists as anti‐platelet therapy" @default.
• W3015311442 cites W142602047 @default.
• W3015311442 cites W1479760463 @default.
• W3015311442 cites W1524907070 @default.
• W3015311442 cites W1530209229 @default.
• W3015311442 cites W1553345686 @default.
• W3015311442 cites W1608454038 @default.
• W3015311442 cites W1847487340 @default.
• W3015311442 cites W1930503019 @default.
• W3015311442 cites W1978712206 @default.
• W3015311442 cites W2003191978 @default.
• W3015311442 cites W2003630942 @default.
• W3015311442 cites W2037182281 @default.
• W3015311442 cites W2053379248 @default.
• W3015311442 cites W2054036069 @default.
• W3015311442 cites W2069694337 @default.
• W3015311442 cites W2083203405 @default.
• W3015311442 cites W2104380573 @default.
• W3015311442 cites W2105735830 @default.
• W3015311442 cites W2136124268 @default.
• W3015311442 cites W2140501627 @default.
• W3015311442 cites W2147184530 @default.
• W3015311442 cites W2149011208 @default.
• W3015311442 cites W2160204917 @default.
• W3015311442 cites W2163919390 @default.
• W3015311442 cites W2278696749 @default.
• W3015311442 cites W2278721721 @default.
• W3015311442 cites W2399554534 @default.
• W3015311442 cites W2415529810 @default.
• W3015311442 cites W2782405145 @default.
• W3015311442 cites W2976166882 @default.
• W3015311442 cites W2991821515 @default.
• W3015311442 cites W311320695 @default.
• W3015311442 doi "https://doi.org/10.1111/jth.14826" @default.
• W3015311442 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32278335" @default.
• W3015311442 hasPublicationYear "2020" @default.
• W3015311442 type Work @default.
• W3015311442 sameAs 3015311442 @default.
• W3015311442 citedByCount "3" @default.
• W3015311442 countsByYear W30153114422020 @default.
• W3015311442 countsByYear W30153114422021 @default.
• W3015311442 crossrefType "journal-article" @default.
• W3015311442 hasAuthorship W3015311442A5002943978 @default.
• W3015311442 hasAuthorship W3015311442A5049732997 @default.
• W3015311442 hasAuthorship W3015311442A5056483000 @default.
• W3015311442 hasAuthorship W3015311442A5059950825 @default.
• W3015311442 hasAuthorship W3015311442A5063653314 @default.
• W3015311442 hasAuthorship W3015311442A5064169659 @default.
• W3015311442 hasAuthorship W3015311442A5070871944 @default.
• W3015311442 hasAuthorship W3015311442A5074359004 @default.
• W3015311442 hasAuthorship W3015311442A5091566580 @default.
• W3015311442 hasBestOaLocation W30153114421 @default.
• W3015311442 hasConcept C126322002 @default.
• W3015311442 hasConcept C150903083 @default.
• W3015311442 hasConcept C185592680 @default.
• W3015311442 hasConcept C202751555 @default.
• W3015311442 hasConcept C207001950 @default.
• W3015311442 hasConcept C26291073 @default.
• W3015311442 hasConcept C2777028646 @default.
• W3015311442 hasConcept C2777628954 @default.
• W3015311442 hasConcept C2777849778 @default.
• W3015311442 hasConcept C3018697912 @default.
• W3015311442 hasConcept C49059817 @default.
• W3015311442 hasConcept C55493867 @default.
• W3015311442 hasConcept C71924100 @default.
• W3015311442 hasConcept C86803240 @default.
• W3015311442 hasConcept C89560881 @default.
• W3015311442 hasConcept C98274493 @default.
• W3015311442 hasConceptScore W3015311442C126322002 @default.
• W3015311442 hasConceptScore W3015311442C150903083 @default.
• W3015311442 hasConceptScore W3015311442C185592680 @default.
• W3015311442 hasConceptScore W3015311442C202751555 @default.
• W3015311442 hasConceptScore W3015311442C207001950 @default.
• W3015311442 hasConceptScore W3015311442C26291073 @default.
• W3015311442 hasConceptScore W3015311442C2777028646 @default.
• W3015311442 hasConceptScore W3015311442C2777628954 @default.
• W3015311442 hasConceptScore W3015311442C2777849778 @default.
• W3015311442 hasConceptScore W3015311442C3018697912 @default.
• W3015311442 hasConceptScore W3015311442C49059817 @default.
• W3015311442 hasConceptScore W3015311442C55493867 @default.
• W3015311442 hasConceptScore W3015311442C71924100 @default.
• W3015311442 hasConceptScore W3015311442C86803240 @default.
• W3015311442 hasConceptScore W3015311442C89560881 @default.
• W3015311442 hasConceptScore W3015311442C98274493 @default.
• W3015311442 hasFunder F4320319992 @default.

• next